Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients.

Vincenza GranataRoberta FuscoMatilde CostaCarmine PiconeDiletta CozziChiara MoroniGiorgia Viola La CasellaAgnese MontaninoRiccardo MontiFrancesca MazzoniRoberta GrassiValeria Grazia MalagninoSalvatore CappabiancaRoberto GrassiVittorio Miele Antonella Petrillo

Published in: Cancers (2021)

Specific radiomic features could be used to select patients with lung adenocarcinoma who would benefit from immunotherapy because a subset of imaging radiomic features useful to predict OS or PFS time were different between the control group and the immunotherapy group.

Keyphrases

computed tomography
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
high resolution
positron emission tomography
squamous cell carcinoma
lymph node metastasis
patient reported outcomes
photodynamic therapy